img

Daratumumab Industry: Global Market Opportunities and Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 432 | Industry : Pharma & Healthcare

Publisher : MRG | Format : PDF

Daratumumab Industry: Global Market Opportunities and Forecast 2024-2034

This report provides a comprehensive analysis of current global Daratumumab market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Daratumumab industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Daratumumab market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Daratumumab Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Daratumumab market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Daratumumab Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Daratumumab industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions


Segmented by Type
100mg Injection
400mg Injection

Segmented by Application
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey


Table of Content

Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Daratumumab Market Status and Forecast (2016-2027)
1.3.2 Global Daratumumab Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Daratumumab Supply by Company
2.1 Global Daratumumab Sales Volume by Company
2.2 Global Daratumumab Sales Value by Company
2.3 Global Daratumumab Price by Company
2.4 Daratumumab Production Location and Sales Area of Main Manufacturers
2.5 Trend of Concentration Rate
3 Global and Regional Daratumumab Market Status by Type
3.1 Daratumumab Type Introduction
3.1.1 100mg Injection
3.1.2 400mg Injection
3.2 Global Daratumumab Market by Type
3.2.1 Global Daratumumab Sales Volume by Type (2016-2021)
3.2.2 Global Daratumumab Sales Value by Type (2016-2021)
3.2.3 Global Daratumumab Price by Type (2016-2021)
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Daratumumab Market Status by Application
4.1 Daratumumab Segment by Application
4.1.1 Multiple Myeloma
4.1.2 Diffuse Large B Cell Lymphoma
4.1.3 Follicular Lymphoma
4.1.4 Mantle Cell Lymphoma
4.1.5 Other
4.2 Global Daratumumab Market by Application
4.2.1 Global Daratumumab Sales Volume by Application (2016-2021)
4.2.2 Global Daratumumab Sales Value by Application (2016-2021)
4.2.3 Global Daratumumab Price by Application (2016-2021)
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Daratumumab Market Status by Region
5.1 Global Daratumumab Market by Region
5.1.1 Global Daratumumab Sales Volume by Region
5.1.2 Global Daratumumab Sales Value by Region
5.2 North America Daratumumab Market Status
5.3 Europe Daratumumab Market Status
5.4 Asia Pacific Daratumumab Market Status
5.5 Central & South America Daratumumab Market Status
5.6 Middle East & Africa Daratumumab Market Status
6 North America Daratumumab Market Status
6.1 North America Daratumumab Market by Country
6.1.1 North America Daratumumab Sales Volume by Country (2016-2021)
6.1.2 North America Daratumumab Sales Value by Country (2016-2021)
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Daratumumab Market Status
7.1 Europe Daratumumab Market by Country
7.1.1 Europe Daratumumab Sales Volume by Country (2016-2021)
7.1.2 Europe Daratumumab Sales Value by Country (2016-2021)
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Daratumumab Market Status
8.1 Asia Pacific Daratumumab Market by Country
8.1.1 Asia Pacific Daratumumab Sales Volume by Country (2016-2021)
8.1.2 Asia Pacific Daratumumab Sales Value by Country (2016-2021)
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Daratumumab Market Status
9.1 Central & South America Daratumumab Market by Country
9.1.1 Central & South America Daratumumab Sales Volume by Country (2016-2021)
9.1.2 Central & South America Daratumumab Sales Value by Country (2016-2021)
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Daratumumab Market Status
10.1 Middle East & Africa Daratumumab Market by Country
10.1.1 Middle East & Africa Daratumumab Sales Volume by Country (2016-2021)
10.1.2 Middle East & Africa Daratumumab Sales Value by Country (2016-2021)
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Supply Chain and Manufacturing Cost Analysis
11.1 Supply Chain Analysis
11.2 Production Process Chart Analysis
11.3 Raw Materials and Key Suppliers Analysis
11.3.1 Raw Materials Introduction
11.3.2 Raw Materials Key Suppliers List
11.4 Daratumumab Manufacturing Cost Analysis
11.5 Daratumumab Sales Channel and Distributors Analysis
11.5.1 Daratumumab Sales Channel
11.5.2 Daratumumab Distributors
11.6 Daratumumab Downstream Major Buyers
12 Global Daratumumab Market Forecast by Type and by Application
12.1 Global Daratumumab Sales Volume and Sales Value Forecast (2022-2027)
12.2 Global Daratumumab Forecast by Type
12.2.1 Global Daratumumab Sales Volume Forecast by Type
12.2.2 Global Daratumumab Sales Value Forecast by Type
12.2.3 Global Daratumumab Price Forecast by Type
12.3 Global Daratumumab Forecast by Application
12.3.1 Global Daratumumab Sales Volume Forecast by Application
12.3.2 Global Daratumumab Sales Value Forecast by Application
12.3.3 Global Daratumumab Price Forecast by Application
13 Global Daratumumab Market Forecast by Region/Country
13.1 Global Daratumumab Market Forecast by Region (2022-2027)
13.1.1 Global Daratumumab Sales Volume Forecast by Region (2022-2027)
13.1.2 Global Daratumumab Sales Value Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Johnson&Johnson
14.1.1 Company Information
14.1.2 Daratumumab Product Introduction
14.1.3 Johnson&Johnson Daratumumab Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
14.1.4 SWOT Analysis
...
15 Conclusion
16 Methodology

List of Figure

List of Tables

Table Global Daratumumab Sales Value and CAGR by Region (2016-2027)
Table Global Daratumumab Sales Volume by Company (2019-2021)
Table Global Daratumumab Sales Volume Market Share by Company (2019-2021)
Table Global Daratumumab Sales Value by Company (2019-2021)
Table Global Daratumumab Sales Value and CAGR by Region (2016-2027)
Table Global Daratumumab Price by Company (2019-2021)
Table Main Manufacturers Daratumumab Product Location and Sales Area
Table Global Daratumumab Sales Value by Company (2019-2021)
Table Global Daratumumab Sales Volume by Type (2016-2021)
Table Global Daratumumab Sales Volume Market Share by Type (2016-2021)
Table Global Daratumumab Sales Value by Type (2016-2021)
Table Global Daratumumab Sals Value Market Share by Type (2016-2021)
Table Global Daratumumab Price by Type (2016-2021)
Table North America Daratumumab Sales Volume by Type (2016-2021)
Table Global Daratumumab Sales Value by Type (2016-2021)
Table Europe Daratumumab Sales Volume by Type (2016-2021)
Table Europe Daratumumab Sales Volume Market Share by Type (2016-2021)
Table Asia Pacific Daratumumab Sales Volume by Type (2016-2021)
Table Asia Pacific Daratumumab Sales Volume Market Share by Type (2016-2021)
Table Central & South America Daratumumab Sales Volume by Type (2016-2021)
Table Central & South America Pacific Daratumumab Sales Volume Market Share by Type (2016-2021)
Table Middle East & Africa Daratumumab Sales Volume by Type (2016-2021)
Table Middle East & Africa Daratumumab Sales Volume Market Share by Type (2016-2021)
Table Global Daratumumab Sales Volume by Application (2016-2021)
Table Global Daratumumab Sales Volume Market Share by Application (2016-2021)
Table Global Daratumumab Sales Value by Application (2016-2021)
Table Global Daratumumab Value Market Share by Application (2016-2021)
Table Global Daratumumab Price by Application (2016-2021)
Table North America Daratumumab Sales Volume by Application (2016-2021)
Table Global Daratumumab Sales Value by Application (2016-2021)
Table Europe Daratumumab Sales Volume by Application (2016-2021)
Table Europe Daratumumab Sales Volume Market Share by Application (2016-2021)
Table Asia Pacific Daratumumab Sales Volume by Application (2016-2021)
Table Asia Pacific Daratumumab Sales Volume Market Share by Application (2016-2021)
Table Central & South America Daratumumab Sales Volume by Application (2016-2021)
Table Central & South America Pacific Daratumumab Sales Volume Market Share by Application (2016-2021)
Table Middle East & Africa Daratumumab Sales Volume by Application (2016-2021)
Table Middle East & Africa Daratumumab Sales Volume Market Share by Application (2016-2021)
Table Global Daratumumab Sales Volume by Region (2016-2021)
Table Global Daratumumab Sales Volume Market Share by Region (2016-2021)
Table Global Daratumumab Sales Value by Region (2016-2021)
Table Global Daratumumab Value Market Share by Region (2016-2021)
Table North America Daratumumab Sales Volume by Country (2016-2021)
Table North America Daratumumab Sales Volume Market Share by Country (2016-2021)
Table Global Daratumumab Sales Value by Region/Country (2016-2021)
Table North America Daratumumab Value Market Share by Country (2016-2021)
Table Europe Daratumumab Sales Volume by Country (2016-2021)
Table Europe Daratumumab Sales Volume Market Share by Country (2016-2021)
Table Europe Daratumumab Sales Value by Country (2016-2021)
Table Europe Daratumumab Value Market Share by Country (2016-2021)
Table Asia Pacific Daratumumab Sales Volume by Country (2016-2021)
Table Asia Pacific Daratumumab Sales Volume Market Share by Country (2016-2021)
Table Asia Pacific Daratumumab Sales Value by Country (2016-2021)
Table Asia Pacific Daratumumab Value Market Share by Country (2016-2021)
Table Central & South America Daratumumab Sales Volume by Country (2016-2021)
Table Central & South America Daratumumab Sales Volume Market Share by Country (2016-2021)
Table Central & South America Daratumumab Sales Value by Country (2016-2021)
Table Central & South America Daratumumab Value Market Share by Country (2016-2021)
Table Middle East & Africa Daratumumab Sales Volume by Country (2016-2021)
Table Middle East & Africa Daratumumab Sales Volume Market Share by Country (2016-2021)
Table Middle East & Africa Daratumumab Sales Value by Country (2016-2021)
Table Middle East & Africa Daratumumab Value Market Share by Country (2016-2021)
Table Daratumumab Raw Materials Key Suppliers List
Table Daratumumab Distributors List
Table Daratumumab Buyers List
Table Global Daratumumab Sales Volume Forecast by Type (2022-2027)
Table Global Daratumumab Sales Volume Market Share Forecast by Type (2022-2027)
Table Global Daratumumab Value Forecast by Type (2022-2027)
Table Global Daratumumab Value Market Share Forecast by Type (2022-2027)
Table Global Daratumumab Price Forecast by Type (2022-2027)
Table Global Daratumumab Sales Volume Forecast by Application (2022-2027)
Table Global Daratumumab Value Forecast by Type (2022-2027)
Table Global Daratumumab Value Forecast by Application (2022-2027)
Table Global Daratumumab Value Market Share Forecast by Application (2022-2027)
Table Global Daratumumab Price Forecast by Application (2022-2027)
Table Global Daratumumab Sales Volume Forecast by Region (2022-2027)
Table Global Daratumumab Value Forecast by Application (2022-2027)
Table Global Daratumumab Value Forecast by Region (2022-2027)
Table Global Daratumumab Value Market Share Forecast by Region (2022-2027)
Table Johnson&Johnson Company Information
Table Johnson&Johnson Product Introduction
Table Global Daratumumab Value Forecast by Region (2022-2027)